NEXTBio Capital Management’s Entera Bio ENTX Stock Holding History

NEXTBio Capital Management’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.51M	Buy	+2,923,937	New	+$7.81M	3.63%	12

Other funds holding ENTX

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

NEXTBio Capital Management's ENTX Position: Q3 2026 in Review

NEXTBio Capital Management opened a new position in Entera Bio (ENTX) in Q3 2026: 2,923,937 shares worth $8.51M. The stake represents 3.63% of the portfolio and ranks #12 among its holdings.

21 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

NEXTBio Capital Management held 2,923,937 shares of Entera Bio worth $8.51M as of Q3 2026.
Entera Bio was a new NEXTBio Capital Management position in Q3 2026.
Entera Bio made up 3.63% of NEXTBio Capital Management's portfolio in Q3 2026, its #12 holding.
21 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on NEXTBio Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.